Kidswell Bio (4584) · InitiativeRestated
Securing specialist talent for regenerative medicine, next-generation modalities and overseas operations
First written in FY2023. 1 of 2 entries say "Restated". Latest entry: FY2025.
2entries
3years
0from disclosures
How it moved
Same theme, other companies
Strengthening the recruitment and development of advanced technical and IT specialistsA theme 257 companies write about · 11 as a headwind · 264 as a tailwind
42 other companies' latest entry also says "Restated".
Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 185 companies compared. The sentences above are computed from all 185.Comparing 200 of the theme's 275 threads.Full recordFilings, disclosures and news, newest first
- FY2025RestatedAnnual report
「• Recruitment of biotechnology personnel with knowledge, skills and experience in biopharmaceuticals • Recruitment of global personnel in anticipation of expanding business overseas • Establishment of a compensation system comparable with those of competitors」
The Company has reconfirmed its policy of establishing a competitive compensation system in addition to recruiting biotechnology specialists and global personnel. - FY2023First statedAnnual report
「• Recruitment of personnel with knowledge and experience in regenerative medicine, including cell therapy • Recruitment of personnel with expertise in next-generation modalities • Recruitment of global personnel in anticipation of expanding business overseas」
The Company has for the first time set out specific recruitment policies for personnel with the expertise required in regenerative medicine, next-generation modalities and overseas businesses.